Healthscore 623·6 metrosupdated 1h ago
FDA Approves Mounjaro for Heart Attack and Stroke Prevention in Diabetics
The FDA has expanded the approval of the diabetes drug Mounjaro to prevent heart attacks and strokes in high-risk adults with type 2 diabetes. Eli Lilly, the drug's manufacturer, highlights its effectiveness in reducing cardiovascular risks.
Where it's breaking
Local coverage
FDA Approves Mounjaro for Heart Attack and Stroke Prevention in Diabetics
FDA Approves Mounjaro to Reduce Cardiovascular Risks in Diabetic Patients
FDA expands Mounjaro approval for heart attack and stroke prevention
FDA expands Mounjaro approval for heart attack and stroke prevention
Mounjaro Approved by FDA to Reduce Cardiovascular Risks in Diabetic Patients
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.